11,931 Shares in The Clorox Company $CLX Bought by Convergence Investment Partners LLC

Convergence Investment Partners LLC bought a new position in The Clorox Company (NYSE:CLX) in the 4th quarter, Holdings Channel.com reports. The fund bought 11,931 shares of the company’s stock, valued at approximately $1,203,000.

Other hedge funds also recently bought and sold shares of the company. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Clorox by 64.2% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock valued at $3,173,000 after purchasing an additional 10,065 shares during the last quarter. Wilkins Investment Counsel Inc. boosted its holdings in shares of Clorox by 250.6% during the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after purchasing an additional 39,360 shares during the last quarter. ProShare Advisors LLC boosted its holdings in shares of Clorox by 11.7% during the 3rd quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock valued at $159,922,000 after purchasing an additional 136,135 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Clorox by 27.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock valued at $114,506,000 after purchasing an additional 197,330 shares during the last quarter. Finally, Occidental Asset Management LLC bought a new position in shares of Clorox during the 3rd quarter valued at about $2,115,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 0.8%

Shares of NYSE:CLX opened at $90.47 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $136.69. The company has a 50-day moving average price of $101.99 and a 200 day moving average price of $106.96. The company has a market cap of $10.94 billion, a price-to-earnings ratio of 14.69, a PEG ratio of 0.47 and a beta of 0.59.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the firm earned $1.45 EPS. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts predict that The Clorox Company will post 5.63 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were issued a $1.24 dividend. The ex-dividend date of this dividend was Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.5%. Clorox’s dividend payout ratio (DPR) is presently 80.52%.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 price objective on shares of Clorox in a report on Friday, May 1st. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. Jefferies Financial Group dropped their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Evercore reissued an “underperform” rating and set a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. Finally, UBS Group dropped their price objective on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $103.73.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.